BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 29768767)

  • 21. Assessing patient readiness for the clinical adoption of personalized medicine.
    Issa AM; Tufail W; Hutchinson J; Tenorio J; Baliga MP
    Public Health Genomics; 2009; 12(3):163-9. PubMed ID: 19204419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomics, personalized medicine, and heart failure.
    Mestroni L; Taylor MR
    Discov Med; 2011 Jun; 11(61):551-61. PubMed ID: 21712021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is personalized medicine a dream or a reality?
    Morse BL; Kim RB
    Crit Rev Clin Lab Sci; 2015 Feb; 52(1):1-11. PubMed ID: 25181036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pharmacogenomics].
    Nakatani K; Nobori T
    Rinsho Byori; 2013 Nov; 61(11):1018-25. PubMed ID: 24450107
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Practical perspectives of personalized healthcare in oncology.
    Hodgson DR; Wellings R; Harbron C
    N Biotechnol; 2012 Sep; 29(6):656-64. PubMed ID: 22426411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Personalized medicine: elusive dream or imminent reality?
    Lesko LJ
    Clin Pharmacol Ther; 2007 Jun; 81(6):807-16. PubMed ID: 17505496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overcoming regulatory and economic challenges facing pharmacogenomics.
    Cohen JP
    N Biotechnol; 2012 Sep; 29(6):751-6. PubMed ID: 22370122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Introductory remarks by chairpersons].
    Kumagai S; Nobori T
    Rinsho Byori; 2013 May; 61(5):419-20. PubMed ID: 23947181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Personalized diagnostics and biosensors: a review of the biology and technology needed for personalized medicine.
    Ahmed MU; Saaem I; Wu PC; Brown AS
    Crit Rev Biotechnol; 2014 Jun; 34(2):180-96. PubMed ID: 23607309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BeadArray-based solutions for enabling the promise of pharmacogenomics.
    Fan JB; Hu S; Craumer W; Barker D
    Biotechniques; 2005 Oct; 39(10 Suppl):S583-8. PubMed ID: 18957041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized medicine.
    Jain KK
    Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers and personalized risk stratification for patients with clinically localized prostate cancer.
    Costa-Pinheiro P; Patel HR; Henrique R; Jerónimo C
    Expert Rev Anticancer Ther; 2014 Nov; 14(11):1349-58. PubMed ID: 25148431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenomics and the challenge of health disparities.
    Lee SS
    Public Health Genomics; 2009; 12(3):170-9. PubMed ID: 19204420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of pharmacoproteomics in the development of personalized medicine.
    Jain KK
    Pharmacogenomics; 2004 Apr; 5(3):331-6. PubMed ID: 15102547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
    Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
    Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Metabolomics Approach to Pharmacotherapy Personalization.
    Balashova EE; Maslov DL; Lokhov PG
    J Pers Med; 2018 Sep; 8(3):. PubMed ID: 30189667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology: a paradigm for individualized medicine.
    Waldman SA; Kraft WK; Nelson TJ; Terzic A
    Biomark Med; 2009 Dec; 3(6):679-84. PubMed ID: 20477706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality by design (QbD) approach of pharmacogenomics in drug designing and formulation development for optimization of drug delivery systems.
    Gupta S; Jhawat V
    J Control Release; 2017 Jan; 245():15-26. PubMed ID: 27871989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.